Skip to main content
Clinical Trials/NCT05295563
NCT05295563
Completed
Not Applicable

Effects of Repeated Botulinum Toxin Injections in Lower Extremity Muscles on Muscle Morphology and Functionality in Children With Cerebral Palsy

Gazi University1 site in 1 country29 target enrollmentMay 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral Palsy
Sponsor
Gazi University
Enrollment
29
Locations
1
Primary Endpoint
Muscle morphology
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

One of the disorders observed in children with cerebral palsy (CP) is abnormal muscle tone, and the most common tone problem is spasticity. Botulinum toxin A (BoNT-A) injections are frequently used to reduce spasticity in CP rehabilitation. BoNT-A injections can be administered as a single dose, and some patients require repeated injections. The aim of this study was to examine the effects of repeated BoNT-A applications applied to the gastrocnemius muscle of children with CP on muscle morphology and functionality.

Detailed Description

The study will be planned to include 50 children with CP. The children will be divided into two groups.Children who had been injected once or twice before were included in one group; children who received 3 or more injections were included in the other group.Gastrocnemius muscle morphology (cross-sectional area, muscle thickness, fascicle length, pennation angle) was evaluated by ultrasonography, muscle stiffness was evaluated by shear wave ultrasound elastography, and muscle vascularization was evaluated by Superb Microvascular Imaging method by an experienced radiologist. Functionality of children with CP was evaluated with gross motor function measure (GMFM), time up go test, squat test and vertical jumping tests by an experienced pediatric physiotherapist.

Registry
clinicaltrials.gov
Start Date
May 1, 2021
End Date
May 31, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kamile Uzun Akkaya

Principal Investigator

Gazi University

Eligibility Criteria

Inclusion Criteria

  • Children with unilateral and bilateral, ambulatory, spastic CP, aged 5-18 years
  • Children who had previously been injected with BoNT-A into the gastrocnemius muscle

Exclusion Criteria

  • Children with dyskinetic, ataxic, and hypotonic type CP
  • Children with a history of any surgical operation or botulinum toxin injection treatment in the previous 6 months

Outcomes

Primary Outcomes

Muscle morphology

Time Frame: Through study completion, an average of 1 year

Gastrocnemius muscle morphology will be evaluated by ultrasonography by an experienced radiologist.

Functionality 1

Time Frame: Through study completion, an average of 1 year

One of the functionality evaluations of children with CP was Gross Motor Funtion Mesaurement (GMFM) by an experienced pediatric physiotherapist.

Functionality 4

Time Frame: Through study completion, an average of 1 year

One of the functionality evaluations of children with CP was vertical jumping test by an experienced pediatric physiotherapist.

Functionality 3

Time Frame: Through study completion, an average of 1 year

One of the functionality evaluations of children with CP was squat test by an experienced pediatric physiotherapist.

Muscle stiffness

Time Frame: Through study completion, an average of 1 year

Muscle stiffness will be evaluated by shear wave ultrasound elastography by an experienced radiologist.

Muscle vascularization

Time Frame: Through study completion, an average of 1 year

Muscle vascularization was evaluated by Superb Microvascular Imaging method by an experienced radiologist.

Functionality 2

Time Frame: Through study completion, an average of 1 year

One of the functionality evaluations of children with CP was time up go test by an experienced pediatric physiotherapist.

Study Sites (1)

Loading locations...

Similar Trials